58 related articles for article (PubMed ID: 11709712)
1. Expression and stabilization of the MCT-1 protein by DNA damaging agents.
Herbert GB; Shi B; Gartenhaus RB
Oncogene; 2001 Oct; 20(46):6777-83. PubMed ID: 11709712
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of MCT-1 by p44/42 MAPK is required for its stabilization in response to DNA damage.
Nandi S; Reinert LS; Hachem A; Mazan-Mamczarz K; Hagner P; He H; Gartenhaus RB
Oncogene; 2007 Apr; 26(16):2283-9. PubMed ID: 17016429
[TBL] [Abstract][Full Text] [Related]
3. A novel candidate oncogene, MCT-1, is involved in cell cycle progression.
Prosniak M; Dierov J; Okami K; Tilton B; Jameson B; Sawaya BE; Gartenhaus RB
Cancer Res; 1998 Oct; 58(19):4233-7. PubMed ID: 9766643
[TBL] [Abstract][Full Text] [Related]
4. Increased G1 cyclin/cdk activity in cells overexpressing the candidate oncogene, MCT-1.
Dierov J; Prosniak M; Gallia G; Gartenhaus RB
J Cell Biochem; 1999 Sep; 74(4):544-50. PubMed ID: 10440924
[TBL] [Abstract][Full Text] [Related]
5. The MCT-1 oncogene product impairs cell cycle checkpoint control and transforms human mammary epithelial cells.
Hsu HL; Shi B; Gartenhaus RB
Oncogene; 2005 Jul; 24(31):4956-64. PubMed ID: 15897892
[TBL] [Abstract][Full Text] [Related]
6. Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells.
Jirmanova L; Afanassieff M; Gobert-Gosse S; Markossian S; Savatier P
Oncogene; 2002 Aug; 21(36):5515-28. PubMed ID: 12165850
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
[TBL] [Abstract][Full Text] [Related]
8. Cell-cycle deregulation in BALB/c 3T3 cells transformed by 1,2-dibromoethane and folpet pesticides.
Santucci MA; Mercatali L; Brusa G; Pattacini L; Barbieri E; Perocco P
Environ Mol Mutagen; 2003; 41(5):315-21. PubMed ID: 12802801
[TBL] [Abstract][Full Text] [Related]
9. Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.
Ishii H; Mimori K; Inageta T; Murakumo Y; Vecchione A; Mori M; Furukawa Y
Mol Cancer Res; 2005 Mar; 3(3):130-8. PubMed ID: 15798093
[TBL] [Abstract][Full Text] [Related]
10. MCT-1 protein interacts with the cap complex and modulates messenger RNA translational profiles.
Reinert LS; Shi B; Nandi S; Mazan-Mamczarz K; Vitolo M; Bachman KE; He H; Gartenhaus RB
Cancer Res; 2006 Sep; 66(18):8994-9001. PubMed ID: 16982740
[TBL] [Abstract][Full Text] [Related]
11. [Changes in the activity of cyclin-kinase complexes governing cell transition from G1 phase to DNA replication phase in E1A + c-Ha-ras transformants transfected with the bcl-2 gene].
Neliudova AM; Aksenov ND; Pospelova TV
Tsitologiia; 2003; 45(2):149-57. PubMed ID: 12722479
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of proliferation of hepatic stellate cells by taurine is mediated via regulating cell cycle proteins].
Chen YX; Chen SW; Zhang XR; Liu S; Xie WF; Li S
Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):571-4. PubMed ID: 16092977
[TBL] [Abstract][Full Text] [Related]
13. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
Hsiang CH; Straus DS
Oncogene; 2002 Mar; 21(14):2212-26. PubMed ID: 11948404
[TBL] [Abstract][Full Text] [Related]
14. Id3 is a novel regulator of p27kip1 mRNA in early G1 phase and is required for cell-cycle progression.
Chassot AA; Turchi L; Virolle T; Fitsialos G; Batoz M; Deckert M; Dulic V; Meneguzzi G; Buscà R; Ponzio G
Oncogene; 2007 Aug; 26(39):5772-83. PubMed ID: 17404577
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 induction through IkappaB kinase beta/nuclear factor-kappaB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes.
Ouyang W; Ma Q; Li J; Zhang D; Liu ZG; Rustgi AK; Huang C
Cancer Res; 2005 Oct; 65(20):9287-93. PubMed ID: 16230390
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
[TBL] [Abstract][Full Text] [Related]
18. Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity.
Kasiappan R; Shih HJ; Chu KL; Chen WT; Liu HP; Huang SF; Choy CO; Shu CL; Din R; Chu JS; Hsu HL
Mol Cancer Res; 2009 Apr; 7(4):536-48. PubMed ID: 19372582
[TBL] [Abstract][Full Text] [Related]
19. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
20. Translational regulation of cyclin D1 by 15-deoxy-delta(12,14)-prostaglandin J(2).
Campo PA; Das S; Hsiang CH; Bui T; Samuel CE; Straus DS
Cell Growth Differ; 2002 Sep; 13(9):409-20. PubMed ID: 12354750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
